Trials / Active Not Recruiting
Active Not RecruitingNCT05047965
An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer
Evaluation of MRI With Dixon Based Sequences in the Detection of Prostate Cancer
- Status
- Active Not Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 65 (estimated)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial studies the use of magnetic resonance imaging (MRI) with Dixon based imaging sequences in detecting prostate cancer. MRI uses radio waves and a powerful magnet linked to a computer to create detailed pictures of areas inside the body. Researchers hope to learn if using a modified MRI scan technique with Dixon based imaging sequencing will help to produce better images of prostate cancer than the standard of care MRI scan technique.
Detailed description
PRIMARY OBJECTIVES: I. Evaluate prospectively the accuracy of Dixon based sequences in detection of intraprostatic tumor nodules. II. Determine the sensitivity, specificity, positive and negative predictive value of Dixon based sequences in assessment of extraprostatic tumor extension and lymph node involvement. SECONDARY OBJECTIVES: I. Compare the accuracy of Dixon based sequences versus multiparametric diffusion weighted imaging including diffusion tensor imaging in tumor detection and extraprostatic extension. II. Compare the accuracy of Dixon based sequences in detection of transition zone tumors. III. Determine the optimal scanning parameters for Dixon based sequences in the imaging of prostate adenocarcinoma. OUTLINE: Patients undergo MRI with additional Dixon based sequences with fat and water over a total of 49 minutes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Dixon MRI | Undergo Dixon MRI |
| PROCEDURE | Magnetic Resonance Imaging | Undergo standard MRI |
Timeline
- Start date
- 2013-04-25
- Primary completion
- 2027-02-02
- Completion
- 2027-02-02
- First posted
- 2021-09-17
- Last updated
- 2026-04-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05047965. Inclusion in this directory is not an endorsement.